Rare diseases in Brazil: a nationwide analysis of the diagnostic odyssey
Authors:
- de OliveiraDOde Oliveira
- Bibiana MelloBMBibiana Mello
- Monique Sartori BrochMBMonique Sartori Broch
- Carolina PeçaibesCPCarolina Peçaibes
- Angélica PiovesanaAPAngélica Piovesana
- Claudia Fernandes LoreaCLClaudia Fernandes Lorea
- Mariana Lima ScortegagnaMSMariana Lima Scortegagna
- Gabriella Zanin FigheraGFGabriella Zanin Fighera
- Isadora ViegasIVIsadora Viegas
- Laíse Pauletti BarpLBLaíse Pauletti Barp
- Mateus AlonsoMAMateus Alonso
- Alberto VergaraAVAlberto Vergara
Open Access
- 15 September 2026
- journal article
- research article
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (5) , 107
Abstract
Background: The diagnostic odyssey of individuals with rare diseases is prolonged and associated with clinical, emotional, and financial burden. In Brazil, data on diagnostic delays and their determinants remain scarce. Objective: This study aims to characterize the diagnostic odyssey of individuals with rare diseases using data from the Brazilian Rare Diseases Network (RARAS). Methods: This descriptive cross-sectional study analyzed ambispective data collected from 2018-2025 across RARAS centers nationwide. Diagnostic odyssey was defined as the time between symptom onset and definitive diagnosis. Prenatal and newborn screening diagnoses were excluded. Sociodemographic, clinical and etiological data were collected through a standardized REDCap-based instrument. Results: Among 18,625 unique participants, 12,048 had confirmed diagnoses and 5,984 met criteria for diagnostic odyssey analysis. The mean diagnostic interval was 6.21 years (± 8.41; median 2.94, IQR 0.80–8.13), indicating substantial heterogeneity. Longer delays were observed in individuals with symptom onset during adolescence. Patients referred during hospital admission experienced shorter diagnostic intervals. Regional differences were significant ( p <0.001), with longer intervals in the Southeast region. Mean time to diagnosis ranged from 2.01 (± 2.89) years (achondroplasia) to 16.40 (± 12.59) years (hereditary angioedema). Patients consulted a mean of 5.32 (± 9.63) physicians and accessed 3.15 (± 4.96) healthcare services before diagnosis. Diagnostic intervals varied by race/ethnicity and etiological category, with longer delays among those with molecular diagnoses, while no association was observed with socioeconomic class. Conclusion: The diagnostic odyssey for rare diseases in Brazil remains prolonged and heterogeneous, reflecting structural disparities, healthcare fragmentation, and diagnostic complexity. These findings suggest that delays are not driven solely by limited access to advanced diagnostics, but also by barriers in early recognition, referral pathways, and care coordination, underscoring the need for integrated strategies across the health system.Keywords
Funding Information
- Universidade Federal do Rio Grande do Sul
This publication has 48 references indexed in Scilit:
- Mapping the expressions and impacts of racism on health in Brazil: a scoping reviewThe Lancet Regional Health - Americas, 2025
- Insights From the First 820 Patients From the Brazilian Multicenter Registry of Hereditary Angioedema: The Key Role of Genetic Testing and Targeted TherapiesThe Journal of Allergy and Clinical Immunology: In Practice, 2025
- Challenges in the clinical management of rare diseases and center-based multidisciplinary approach to creating solutionsEuropean Journal of Pediatrics, 2025
- Advancing Equity in Rare Disease Research: Insights From the Undiagnosed Disease NetworkAmerican Journal of Medical Genetics Part A, 2024
- Prevalence and Diagnostic Journey of Friedreich’s Ataxia in the State of São Paulo, BrazilThe Cerebellum, 2024
- A survey of awareness of diagnosis and treatment of rare diseases among healthcare professionals and researchers in IndiaJournal of Biosciences, 2023
- Diagnostic odyssey in amyotrophic lateral sclerosis: diagnostic criteria and realityNeurological Sciences, 2023
- Application of facial analysis Technology in Clinical Genetics: Considerations for diverse populationsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2023
- Genetic services and testing in BrazilJournal of Community Genetics, 2012
- Mucopolysaccharidoses in Brazil: What happens from birth to biochemical diagnosis?American Journal of Medical Genetics Part A, 2008